Nanovibronix Common Stock Net 2014-2025 | NAOV
Nanovibronix common stock net from 2014 to 2025. Common stock net can be defined as the value of common equity ownership.
| Nanovibronix Annual Common Stock Net (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $0 |
| 2021 | $0 |
| 2020 | $0 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $0 |
| 2015 | $0 |
| 2014 | $0 |
| 2013 | $0 |
| Nanovibronix Quarterly Common Stock Net (Millions of US $) |
|
|---|---|
| 2025-03-31 | $0 |
| 2024-12-31 | $0 |
| 2024-09-30 | $0 |
| 2024-06-30 | $0 |
| 2024-03-31 | $0 |
| 2023-12-31 | $0 |
| 2023-09-30 | $0 |
| 2023-06-30 | $0 |
| 2023-03-31 | $0 |
| 2022-12-31 | $0 |
| 2022-09-30 | $0 |
| 2022-06-30 | $0 |
| 2022-03-31 | $0 |
| 2021-12-31 | $0 |
| 2021-09-30 | $0 |
| 2021-06-30 | $0 |
| 2021-03-31 | $0 |
| 2020-12-31 | $0 |
| 2020-09-30 | $0 |
| 2020-06-30 | $0 |
| 2020-03-31 | $0 |
| 2019-12-31 | $0 |
| 2019-09-30 | $0 |
| 2019-06-30 | $0 |
| 2019-03-31 | $0 |
| 2018-12-31 | $0 |
| 2018-09-30 | $0 |
| 2018-06-30 | $0 |
| 2018-03-31 | $0 |
| 2017-12-31 | $0 |
| 2017-09-30 | $0 |
| 2017-06-30 | $0 |
| 2017-03-31 | $0 |
| 2016-12-31 | $0 |
| 2016-09-30 | $0 |
| 2016-06-30 | $0 |
| 2016-03-31 | $0 |
| 2015-12-31 | $0 |
| 2015-09-30 | $0 |
| 2015-06-30 | $0 |
| 2015-03-31 | |
| 2014-12-31 | |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2014-03-31 | $0 |
| 2013-12-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.002B | $0.003B |
| NanoVibronix, Inc. is a medical device company. The Company's products include WoundShield(TM), a patch-based therapeutic ultrasound device which facilitates tissue regeneration and wound healing; PainShield(R), a disposable patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures; UroShield(TM), an ultrasound-based product which is designed to prevent biofilm in urinary catheters; NanoVibronix, lightweight pump which allow contamination-free handling of infected wound exudate and enhanced patient mobility. NanoVibronix, Inc. is based in Melville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $194.768B | 85.31 |
| Thermo Fisher Scientific (TMO) | United States | $153.059B | 18.51 |
| Edwards Lifesciences (EW) | United States | $45.878B | 30.08 |
| Alcon (ALC) | Switzerland | $43.544B | 29.43 |
| IDEXX Laboratories (IDXX) | United States | $43.134B | 49.57 |
| DexCom (DXCM) | United States | $34.227B | 52.90 |
| IQVIA Holdings (IQV) | United States | $27.263B | 15.27 |
| Mettler-Toledo (MTD) | United States | $24.414B | 29.03 |
| STERIS (STE) | Ireland | $23.631B | 26.03 |
| Waters (WAT) | United States | $20.771B | 29.31 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.802B | 0.00 |
| Hologic (HOLX) | United States | $14.521B | 15.78 |
| Sysmex ADR (SSMXY) | Japan | $10.950B | 31.06 |
| Penumbra (PEN) | United States | $9.938B | 78.00 |
| Masimo (MASI) | United States | $9.121B | 33.64 |
| Globus Medical (GMED) | United States | $7.990B | 19.04 |
| Glaukos (GKOS) | United States | $5.902B | 0.00 |
| Teleflex (TFX) | United States | $5.230B | 8.63 |
| TransMedics (TMDX) | United States | $4.533B | 98.54 |
| Integer Holdings (ITGR) | United States | $4.291B | 22.48 |
| PROCEPT BioRobotics (PRCT) | United States | $3.187B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.455B | 14.62 |
| Veracyte (VCYT) | United States | $2.117B | 29.70 |
| Nihon Kohden (NHNKY) | Japan | $2.022B | 23.20 |
| Elekta AB (EKTAY) | Sweden | $1.947B | 17.50 |
| Alphatec Holdings (ATEC) | United States | $1.623B | 0.00 |
| Artivion (AORT) | United States | $1.328B | 124.40 |
| Tandem Diabetes Care (TNDM) | United States | $1.242B | 0.00 |
| OPKO Health (OPK) | United States | $1.047B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.015B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.954B | 5.07 |
| SiBone (SIBN) | United States | $0.802B | 0.00 |
| IRadimed (IRMD) | United States | $0.760B | 38.57 |
| Beta Bionics (BBNX) | United States | $0.631B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.566B | 8.81 |
| RxSight (RXST) | United States | $0.528B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.522B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.514B | 12.05 |
| AxoGen (AXGN) | United States | $0.494B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.474B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.437B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.432B | 11.50 |
| AngioDynamics (ANGO) | United States | $0.403B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.372B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.370B | 0.00 |
| NeuroPace (NPCE) | United States | $0.365B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.334B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.265B | 0.00 |
| 908 Devices (MASS) | United States | $0.256B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.236B | 14.28 |
| Neuronetics (STIM) | United States | $0.230B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.214B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.195B | 0.00 |
| Inogen (INGN) | United States | $0.189B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.172B | 0.00 |
| LENSAR (LNSR) | United States | $0.155B | 0.00 |
| CVRx (CVRX) | United States | $0.153B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.151B | 0.00 |
| Accuray (ARAY) | United States | $0.141B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.124B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.103B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.092B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.40 |
| EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
| InspireMD (NSPR) | United States | $0.070B | 0.00 |
| Spectral AI (MDAI) | United States | $0.063B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.062B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.024B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.33 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |